Navidea Biopharmaceuticals Inc (NAVB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
October 2018
40
About the Report
About the Report
Summary
Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002; MT-2002; Tc99m tilmanocept for Kaposi's, NAS, Cardiovascular diseases, Sentinal Node Biopsy, and Solid tumors lymphatic mapping and NAV4694 for Alzhemier's Disease. Navidea by utilizing its Manocept platform develops multiple precision-targeted products to identify pathways of undetected disease and provide better diagnostic accuracy, clinical decision-making and effective treatment. The company has presence in the US, and the UK. Navidea is headquartered in Dublin, Ohio, the US.
Navidea Biopharmaceuticals Inc (NAVB)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Navidea Biopharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Navidea Raises USD50 Million in Venture Financing 11
Partnerships 12
BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12
Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13
Navidea Biopharm forms Joint Venture with Rheumco 14
Navidea Biopharma Amends Agreement with University of California San Francisco 15
Licensing Agreements 16
Navidea Enters into License Agreement with Norgine for Lymphoseek 16
Equity Offering 17
Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18
Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19
Asset Transactions 20
Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20
Navidea Biopharmaceuticals Inc-Key Competitors 22
Navidea Biopharmaceuticals Inc-Key Employees 23
Navidea Biopharmaceuticals Inc-Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Aug 08, 2018: Navidea Biopharmaceuticals reports second quarter 2018 financial results 25
May 08, 2018: Navidea Biopharmaceuticals Announces First Quarter 2018 Financial Results 26
Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results 29
Aug 08, 2017: Navidea Biopharmaceuticals Reports Second Quarter 2017 Financial Results 31
May 09, 2017: Navidea Biopharmaceuticals Reports First Quarter 2017 Financial Results 32
Mar 29, 2017: Navidea Provides Corporate Update and Reports Full Year 2016 Results 34
Corporate Communications 37
Aug 15, 2018: Navidea Biopharmaceuticals receives noncompliance notice from NYSE American 37
Other Significant Developments 38
Sep 17, 2018: Navidea Biopharmaceuticals announces acceptance into the National Institutes of Health commercialization accelerator program 38
Aug 16, 2018: Navidea Biopharmaceuticals announces details of 2018 Annual General Meeting 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40
List of Figure
List of Figures
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
List of Table
List of Tables
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navidea Biopharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Navidea Biopharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navidea Raises USD50 Million in Venture Financing 11
BIND Therapeutics Enters into Research Agreement with Macrophage Therapeutics 12
Hainan Sinotau Enters into Co-Development Agreement with Navidea for Lymphoseek 13
Navidea Biopharm forms Joint Venture with Rheumco 14
Navidea Biopharma Amends Agreement with University of California San Francisco 15
Navidea Enters into License Agreement with Norgine for Lymphoseek 16
Navidea Biopharma Raises USD3 Million in Private Placement of Shares 17
Navidea Biopharma Plans to Raise up to USD100 in Public Offering of Shares 18
Macrophage Therapeutics Raises USD0.5 Million in First Tranche of Private Placement 19
Cardinal Health Acquires Lymphoseek from Navidea Biopharma 20
Navidea Biopharmaceuticals Inc, Key Competitors 22
Navidea Biopharmaceuticals Inc, Key Employees 23
Navidea Biopharmaceuticals Inc, Subsidiaries 24
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.